These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34535175)

  • 21. Time to recovery and its predictors among adults hospitalized with COVID-19: A prospective cohort study in Ethiopia.
    Abrahim SA; Tessema M; Defar A; Hussen A; Ejeta E; Demoz G; Tereda AB; Dillnessa E; Feleke A; Amare M; Nigatu F; Fufa Y; Refera H; Aklilu A; Kassa M; Kifle T; Whiting S; Tollera G; Abate E
    PLoS One; 2020; 15(12):e0244269. PubMed ID: 33378367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: A structured summary of a study protocol for a randomized controlled trial.
    Hosseini FS; Malektojari A; Ghazizadeh S; Hassaniazad M; Davoodian P; Dadvand H; Nikpoor AR; Nikoofal-Sahlabadi S; Kahoori S; Sepandi M; Hassanipour S; Fathalipour M
    Trials; 2021 Jan; 22(1):4. PubMed ID: 33397429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of clinical, laboratory and chest CT findings of laboratory-confirmed and clinically diagnosed COVID-19 patients at first admission.
    Kuzan TY; Murzoğlu Altıntoprak K; Çiftçi HÖ; Ergül U; Ünal Özdemir NB; Bulut M; Yiyit N
    Diagn Interv Radiol; 2021 May; 27(3):336-343. PubMed ID: 32876570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative analysis of various clinical specimens in detection of SARS-CoV-2 using rRT-PCR in new and follow up cases of COVID-19 infection: Quest for the best choice.
    Sharma K; Aggarwala P; Gandhi D; Mathias A; Singh P; Sharma S; Negi SS; Bhargava A; Das P; Gaikwad U; Wankhede A; Behra A; Nagarkar NM
    PLoS One; 2021; 16(4):e0249408. PubMed ID: 33819290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Profiling serum levels of glutathione reductase and interleukin-10 in positive and negative-PCR COVID-19 outpatients: A comparative study from southwestern Iran.
    Naghashpour M; Ghiassian H; Mobarak S; Adelipour M; Piri M; Seyedtabib M; Golabi S
    J Med Virol; 2022 Apr; 94(4):1457-1464. PubMed ID: 34800305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study.
    Bager P; Wohlfahrt J; Fonager J; Rasmussen M; Albertsen M; Michaelsen TY; Møller CH; Ethelberg S; Legarth R; Button MSF; Gubbels S; Voldstedlund M; Mølbak K; Skov RL; Fomsgaard A; Krause TG;
    Lancet Infect Dis; 2021 Nov; 21(11):1507-1517. PubMed ID: 34171231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Large Retrospective Study of Epidemiological Characteristics of COVID-19 Patients in the North of Iran: Association between SARS-CoV-2 RT-PCR Ct Values with Demographic Data.
    Sadeghi F; Pournajaf A; Halaji M; Chehrazi M; Amiri FH; Amoli SS; Hasanzadeh A; Javanian M; Bayani M; Haddad Zavareh MS; Shokri M; Babazadeh A; Mohammadi M; Mehdinezhad H; Monadi M; Maleh PA; Nouri HR; Daraei A; Pasha MY; Tourani M; Ahmadian SR; Esmailzadeh N; Mirtabar SM; Asadi S; Nasiraie E; Ezami N; Gorjinejad S; Fallhpour K; Fakhraie F; Beheshti Y; Baghershiroodi M; Rasti F; Salehi M; Aleahmad A; Babapour R; Malekzadeh R; Kashi RH; Yahyapour Y
    Int J Clin Pract; 2022; 2022():1455708. PubMed ID: 35685485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study.
    Wolter N; Jassat W; Walaza S; Welch R; Moultrie H; Groome M; Amoako DG; Everatt J; Bhiman JN; Scheepers C; Tebeila N; Chiwandire N; du Plessis M; Govender N; Ismail A; Glass A; Mlisana K; Stevens W; Treurnicht FK; Makatini Z; Hsiao NY; Parboosing R; Wadula J; Hussey H; Davies MA; Boulle A; von Gottberg A; Cohen C
    Lancet; 2022 Jan; 399(10323):437-446. PubMed ID: 35065011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Deeks JJ; Berhane S; Taylor M; Adriano A; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Domen J; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; McInnes MD; Spijker R; Van den Bruel A;
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013705. PubMed ID: 33760236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sociodemographic determinants and clinical risk factors associated with COVID-19 severity: a cross-sectional analysis of over 200,000 patients in Tehran, Iran.
    Sohrabi MR; Amin R; Maher A; Bahadorimonfared A; Janbazi S; Hannani K; Kolahi AA; Zali AR
    BMC Infect Dis; 2021 May; 21(1):474. PubMed ID: 34034649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, south India: a prospective, active surveillance study.
    Laxminarayan R; B CM; G VT; Arjun Kumar KV; Wahl B; Lewnard JA
    Lancet Infect Dis; 2021 Dec; 21(12):1665-1676. PubMed ID: 34399090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of Real Time PCR Cycle Threshold Values in Symptomatic and Asymptomatic COVID-19 Patients].
    Gülbudak H; Karvar Ş; Soydan G; Tezcan Ülger S; Kandemir Ö; Tamer L; Altunkan AA; Özdemir AA; Aslan G
    Mikrobiyol Bul; 2021 Jul; 55(3):435-444. PubMed ID: 34416808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic SARS-CoV-2 Cycle Threshold Value Predicts Disease Severity, Survival, and Six-Month Sequelae in COVID-19 Symptomatic Patients.
    Trunfio M; Venuti F; Alladio F; Longo BM; Burdino E; Cerutti F; Ghisetti V; Bertucci R; Picco C; Bonora S; Di Perri G; Calcagno A
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33670360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial.
    Olagunju A; Fowotade A; Olagunoye A; Ojo TO; Adefuye BO; Fagbamigbe AF; Adebiyi AO; Olagunju OI; Ladipo OT; Akinloye A; Adeagbo BA; Onayade A; Bolaji OO; Happi C; Rannard S; Owen A
    Trials; 2021 Jan; 22(1):3. PubMed ID: 33397457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronavirus Disease 2019 and Chronic Kidney Disease - A Clinical Observational Study.
    Shankar M; Narasimhappa S; MuddeGowda MK; Siddappa MN; Ramprasad K; Lingaraj U
    Saudi J Kidney Dis Transpl; 2021; 32(3):744-753. PubMed ID: 35102917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical characteristics and outcome of hospitalized COVID-19 patients with diabetes: A single-center, retrospective study in Iran.
    Akbariqomi M; Hosseini MS; Rashidiani J; Sedighian H; Biganeh H; Heidari R; Moghaddam MM; Farnoosh G; Kooshki H
    Diabetes Res Clin Pract; 2020 Nov; 169():108467. PubMed ID: 32979419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship of the cycle threshold values of SARS-CoV-2 polymerase chain reaction and total severity score of computerized tomography in patients with COVID 19.
    Karahasan Yagci A; Sarinoglu RC; Bilgin H; Yanılmaz Ö; Sayın E; Deniz G; Guncu MM; Doyuk Z; Barıs C; Kuzan BN; Aslan B; Korten V; Cimsit C
    Int J Infect Dis; 2020 Dec; 101():160-166. PubMed ID: 32992013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of the chest CT score in COVID-19 patients: a cross-sectional study.
    Yazdi NA; Ghadery AH; SeyedAlinaghi S; Jafari F; Jafari S; Hasannezad M; Koochak HE; Salehi M; Manshadi SAD; Meidani M; Hajiabdolbaghi M; Ahmadinejad Z; Khalili H; Mehrabi Nejad MM; Abbasian L
    Virol J; 2021 Nov; 18(1):225. PubMed ID: 34794467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19).
    Urwyler P; Charitos P; Moser S; Heijnen IAFM; Trendelenburg M; Thoma R; Sumer J; Camacho-Ortiz A; Bacci MR; Huber LC; Stüssi-Helbling M; Albrich WC; Sendi P; Osthoff M
    Trials; 2021 Jan; 22(1):1. PubMed ID: 33397449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.